208 related articles for article (PubMed ID: 679196)
61. [Antitumor activity of carminomycin antibiotic used orally].
Shorin VA; Bazhanov VS; Averbukh LA
Antibiotiki; 1976 Nov; 21(11):1005-7. PubMed ID: 1037187
[TBL] [Abstract][Full Text] [Related]
62. [Toxicity and cumulative properties of carminomycin, rubomycin and adriamycin at different times of use].
Lichinitser MR; Syrkin AB
Antibiotiki; 1976 Nov; 21(11):1030-2. PubMed ID: 1020931
[TBL] [Abstract][Full Text] [Related]
63. [Effect of chloramphenicol on the toxic and therapeutic actions of cyclophosphane].
Bogush TA
Antibiot Med Biotekhnol; 1986 Mar; 31(3):199-202. PubMed ID: 3717919
[TBL] [Abstract][Full Text] [Related]
64. Single versus combination chemotherapy of L1210 leukemia.
Koza I; Balázová E; Ujházy V
Neoplasma; 1980; 27(6):691-6. PubMed ID: 7254424
[TBL] [Abstract][Full Text] [Related]
65. [Effect of nitrosomethylurea (NMU) on the growth kinetics and protein biosynthesis in leukemia L1210 cells].
Kukushkina GV; Sokolova IS; Ostrovskaia LA; Gorbacheva LB
Izv Akad Nauk SSSR Biol; 1972; 5():731-6. PubMed ID: 4667390
[No Abstract] [Full Text] [Related]
66. Schedule-dependent synergism for the combination of 1-beta-D-arabinofuranosylcytosine and daunorubicin.
Edelstein M; Vietti T; Valeriote F
Cancer Res; 1974 Feb; 34(2):293-7. PubMed ID: 4810905
[No Abstract] [Full Text] [Related]
67. Combination chemotherapy of L1210 leukemia with platinum compounds and cyclophosphamide plus other selected antineoplastic agents.
Glae GR; Atkins LM; Meischen SJ; Smith AB; Walker EM
J Natl Cancer Inst; 1976 Dec; 57(6):1363-6. PubMed ID: 187805
[TBL] [Abstract][Full Text] [Related]
68. Electronic volume analysis of L1210 chemotherapy.
Zucker RM; Helfman D
Cancer Res; 1976 Dec; 36(12):4434-8. PubMed ID: 1000492
[TBL] [Abstract][Full Text] [Related]
69. Effect of dose, schedule, and route of administration on the in vivo toxicity and antitumor activity of two activated sulfhydryl derivatives of cyclophosphamide.
Ramonas LM; Erickson LC; Ringsdorf H; Zaharko DS
Cancer Res; 1980 Oct; 40(10):3704-8. PubMed ID: 7438053
[TBL] [Abstract][Full Text] [Related]
70. Experimental antitumor activity and toxicity of a new chemotherapeutic agent, BBM 928A.
Rose WC; Schurig JE; Huftalen JB; Bradner WT
Cancer Res; 1983 Apr; 43(4):1504-10. PubMed ID: 6831399
[No Abstract] [Full Text] [Related]
71. [Synthesis, toxicity and antitumor action of carminomycin azine (carminazine)].
Povarov LS; Gol'dberg LE; Bazhanov VS; Shepelevtseva NG; Vertogradova TP
Antibiotiki; 1981 Aug; 26(8):620-3. PubMed ID: 6895293
[TBL] [Abstract][Full Text] [Related]
72. [Carminomycin in the therapy of leukemias].
Vygovskaia IaI; Mazurok AA; Kondrat'eva NA; Orel VG
Antibiotiki; 1982 Aug; 27(8):632-5. PubMed ID: 6957161
[No Abstract] [Full Text] [Related]
73. [Models of preclinical studies of anthracyclines].
Fizames C
Pathol Biol (Paris); 1987 Jan; 35(1):41-8. PubMed ID: 3550611
[TBL] [Abstract][Full Text] [Related]
74. [Blood coagulation system in oncological patients treated with rubomycin, adriamycin and carminomycin].
Zhukovskaia ES; Gorbunova VA; Khvatova NV
Antibiotiki; 1976 Mar; 21(3):273-7. PubMed ID: 1275477
[TBL] [Abstract][Full Text] [Related]
75. Characteristics and response to certain cancer chemotherapeutic agents of an acute lymphocytic leukemia arising in a BALB-c times DBA-2F1 mouse.
Yancey ST; Bleyer WA
Cancer Res; 1974 Aug; 34(8):1866-9. PubMed ID: 4526157
[No Abstract] [Full Text] [Related]
76. Comparative ultrastructural studies of nucleoli of tumor cells treated with adriamycin and the newer anthracyclines, carminomycin and marcellomycin.
Daskal Y; Woodard C; Crooke ST; Busch H
Cancer Res; 1978 Feb; 38(2):467-73. PubMed ID: 202387
[TBL] [Abstract][Full Text] [Related]
77. Antileukemic properties of organoplatinum complexes.
Meischen SJ; Gale GR; Lake LM; Frangakis CJ; Rosenblum MG; Walker EM; Atkins LM; Smith AB
J Natl Cancer Inst; 1976 Oct; 57(4):841-5. PubMed ID: 1003531
[TBL] [Abstract][Full Text] [Related]
78. Therapeutic effects of 9-beta-D-arabinofuranosyladenine and 2'-deoxycoformycin combinations on intracerebral leukemia.
Lee SH; Caron N; Kimball AP
Cancer Res; 1977 Jul; 37(7 Pt 1):1953-5. PubMed ID: 861931
[TBL] [Abstract][Full Text] [Related]
79. Cyclophosphamide. I. Effects of survival and colony-forming cells in BDF1 L-1210-bearing mice.
Pazdernik TL; Uyeki EM
J Pharmacol Exp Ther; 1978 Oct; 207(1):255-61. PubMed ID: 702348
[TBL] [Abstract][Full Text] [Related]
80. Potentiation of concanavalin A-bound L1210 vaccine in vivo by chemotherapeutic agents.
Kataoka T; Kobayashi H; Sakurai Y
Cancer Res; 1978 May; 38(5):1202-7. PubMed ID: 639053
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
